Analytical Data
-
Gene name
FGF20
- Application
-
Alternative Names
FGF20；Fibroblast growth factor 20
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NP95
-
Expression Region
1-211aa
-
AA Sequence
MAPLAEVGGF LGGLEGLGQQ VGSHFLLPPA GERPPLLGER RSAAERSARG GPGAAQLAHL HGILRRRQLY CRTGFHLQIL PDGSVQGTRQ DHSLFGILEF ISVAVGLVSI RGVDSGLYLG MNDKGELYGS EKLTSECIFR EQFEENWYNT YSSNIYKHGD TGRRYFVALN KDGTPRDGAR SKRHQKFTHF LPRPVDPERV PELYKDLLMY T
-
Molecular Weight
23.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fibroblast growth factor 20 (FGF20) is a member of the fibroblast growth factor (FGF) family, which plays a crucial role in various biological processes, including cell proliferation, differentiation, and survival. Emerging studies have highlighted FGF20's significance in neurogenesis, particularly its potential involvement in neurodegenerative diseases and brain development. Research indicates that FGF20 is expressed in specific brain regions and may influence dopaminergic neuron survival, making it a candidate for therapeutic interventions in conditions like Parkinson's disease. Additionally, FGF20 has been shown to interact with specific receptors, activating downstream signaling pathways that are critical for neuronal health. The recombinant form of FGF20 has been developed for various in vitro and in vivo studies to elucidate its functional roles and therapeutic potential. Understanding the mechanisms by which FGF20 operates could pave the way for novel treatments targeting neural repair and regeneration, significantly impacting neuroscience and regenerative medicine. Thus, the research surrounding FGF20 recombinant protein is of substantial interest due to its possible applications in treating neurodegenerative disorders and enhancing our understanding of brain biology.
